Both in Pharmaceuticals
Abbott Laboratories vs Teva Pharmaceutical Industries Limited
Over the past year ABT returned −14.1% and TEVA returned +105.5%; their daily moves had a correlation of 0.14.
ABT −14.1% TEVA +105.5%Growth of $1, one year, split-adjusted
| Metric | ABT | TEVA |
|---|---|---|
| Price | $106.20 | $42.09 |
| Market cap | $183.77B | $49.09B |
| Today | +1.56% | +1.50% |
| 1 month | +9.8% | +7.1% |
| 6 months | +18.7% | +20.4% |
| Year to date | −15.2% | +34.9% |
| 1 year | −14.7% | +108.1% |
| Revenue growth (YoY) | +13.0% | −0.8% |
| Gross margin | 57.7% | 52.0% |
| Net margin | 7.4% | −13.9% |
| P/E (TTM) | 33.9× | 69.4× |
| Price / sales | 3.9× | 2.8× |
| Net cash | -$27.00B | -$12.94B |
| Dividend yield | 2.37% | — |
| Volatility (60d) | 21.3% | 27.4% |
| Short % of float | 1.0% | 2.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).